GIP (Glucose-Dependent Insulinotropic Polypeptide) An incretin hormone that enhances insulin secretion when blood glucose rises
View Source All references are peer-reviewed preclinical or clinical studies cited for informational purposes only
Appetite Suppression and ADHD Medication Side Effects Many ADHD stimulants already reduce appetite as a known side effect, affecting 2030% of people on these medications
We analyzed key clinical trials, including SUSTAIN 6, PIONEER 6, STEP HFpEF, STEP HFpEF DM, and supportive studies on glucagon-like peptide receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors, alongside mechanistic insights into semaglutides metabolic, anti-inflammatory, and decongestive effects
High-dose semaglutide ramps up weight loss, says Novo A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their body weight
This is why mannitol can often be found with pH adjusting ingredients, such as sodium bicarbonate